Circular RNAs in the pathogenesis of SARS-CoV-2: potential diagnostic biomarkers and therapeutic targets

被引：0
|
作者：
JiaJie Wu [1 ]
Lele Li [1 ]
Wei Xu [1 ]
Xiaoping Xia [1 ]
Yingping Wu [1 ]
机构：
[1] the Fourth Affiliated Hospital of School of medicine,Department of Clinical Laboratory
[2] International Institutes of Medicine,undefined
[3] Zhejiang University,undefined
来源：
Functional & Integrative Genomics | 2025年 / 25卷 / 1期
关键词：
Circular RNAs; SARS-CoV-2; Non-coding RNA; Virus-host interaction; RNA treatment;
D O I：
10.1007/s10142-024-01509-6
中图分类号：
学科分类号：
摘要：
Since December 2019, the global dissemination of a novel coronavirus has precipitated a notable public health crisis, prompting considerable interest and scrutiny from governmental and scholarly entities. Substantial research efforts have been dedicated to exploring diverse facets of this novel coronavirus, encompassing its pathogenesis, transmission dynamics, and therapeutic interventions. Recent findings suggest that circular RNAs (circRNAs) exert a pivotal influence on modulating viral infectivity and immune defense mechanisms. The detection of differentially expressed circRNAs in individuals afflicted with SARS-CoV-2 signifies a noteworthy advancement in understanding the molecular mechanisms underpinning viral pathogenesis.
引用
收藏
相关论文
共 50 条
  • [41] Circular RNAs Serve as Novel Biomarkers and Therapeutic Targets in Cancers
    Fang, Shuai
    Pan, Jinchang
    Zhou, Chengwei
    Tian, Hui
    He, Jinxian
    Shen, Weiyu
    Jin, Xiaofeng
    Meng, Xiaodan
    Jiang, Nan
    Gong, Zhaohui
    CURRENT GENE THERAPY, 2019, 19 (02) : 125 - 133
  • [42] Circular RNAs as a novel class of potential therapeutic and diagnostic biomarkers in reproductive biology/diseases
    Wanyu Song
    Xiuli Chen
    Haiying Wu
    Neda Rahimian
    European Journal of Medical Research, 29 (1)
  • [43] SARS-CoV-2, SARS-CoV, and MERS-CoV encode circular RNAs of spliceosome-independent origin
    Yang, Shaomin
    Zhou, Hong
    Liu, Mingde
    Jaijyan, Dabbu
    Cruz-Cosme, Ruth
    Ramasamy, Santhamani
    Subbian, Selvakumar
    Liu, Dongxiao
    Xu, Jiayu
    Niu, Xiaoyu
    Li, Yaolan
    Xiao, Lizu
    Tyagi, Sanjay
    Wang, Qiuhong
    Zhu, Hua
    Tang, Qiyi
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (07) : 3203 - 3222
  • [44] SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
    Shivshankar, Pooja
    Karmouty-Quintana, Harry
    Mills, Tingting
    Doursout, Marie-Francoise
    Wang, Yanyu
    Czopik, Agnieszka K.
    Evans, Scott E.
    Eltzschig, Holger K.
    Yuan, Xiaoyi
    INFLAMMATION, 2022, 45 (04) : 1430 - 1449
  • [45] Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
    Ho, Gilbert
    Ali, Alysha
    Takamatsu, Yoshiki
    Wada, Ryoko
    Masliah, Eliezer
    Hashimoto, Makoto
    DRUG DISCOVERY TODAY, 2021, 26 (08) : 2036 - 2044
  • [46] SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
    Pooja Shivshankar
    Harry Karmouty-Quintana
    Tingting Mills
    Marie-Francoise Doursout
    Yanyu Wang
    Agnieszka K. Czopik
    Scott E. Evans
    Holger K. Eltzschig
    Xiaoyi Yuan
    Inflammation, 2022, 45 : 1430 - 1449
  • [47] MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma
    Turai, Peter Istvan
    Nyiro, Gabor
    Butz, Henriett
    Patocs, Attila
    Igaz, Peter
    CANCERS, 2021, 13 (07)
  • [48] Peptide Targets to SARS-CoV-2
    Mandal, Santi M.
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2020, 12 (04) : 234 - +
  • [49] Remdesivir, a compound with therapeutic potential against SARS-CoV-2
    Paul Bautista-Pariona, Anthony
    Karen Rangel-Tovar, Angela
    Efrain Failoc-Rojas, Virgilio
    SALUD PUBLICA DE MEXICO, 2021, 63 (02): : 162 - 163
  • [50] Potential therapeutic effects of Resveratrol against SARS-CoV-2
    Ramdani, L. H.
    Bachari, K.
    ACTA VIROLOGICA, 2020, 64 (03) : 276 - 280
12345